CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.79 HKD | +2.13% |
|
-2.04% | -6.63% |
| Apr. 18 | China Resources Pharma Unit Issues 3 Billion Yuan Bonds | MT |
| Apr. 12 | China Resources Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Three Months Ended 31 March 2024 | CI |
| Sales 2023 | 245B 31.24B | Sales 2024 * | 283B 36.12B | Capitalization | 30.09B 3.84B |
|---|---|---|---|---|---|
| Net income 2023 | 3.85B 492M | Net income 2024 * | 4.6B 588M | EV / Sales 2023 | 0.28 x |
| Net Debt 2023 | 36.2B 4.62B | Net Debt 2024 * | 33.98B 4.34B | EV / Sales 2024 * | 0.23 x |
| P/E ratio 2023 |
8.41
x | P/E ratio 2024 * |
6.61
x | Employees | 72,986 |
| Yield 2023 |
3% | Yield 2024 * |
3.47% | Free-Float | 27.95% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.13% | ||
| 1 week | -2.04% | ||
| Current month | -4.20% | ||
| 1 month | -7.17% | ||
| 3 months | -1.84% | ||
| 6 months | -1.24% | ||
| Current year | -6.63% |
1 week
4.62
4.81
1 month
4.625.30
Current year
4.455.56
1 year
4.458.13
3 years
3.188.13
5 years
3.1811.76
10 years
3.1813.16
| Managers | Title | Age | Since |
|---|---|---|---|
Xiao Song Bai
CEO | Chief Executive Officer | 52 | 22-01-13 |
Rong Hui Deng
DFI | Director of Finance/CFO | 46 | 23-06-12 |
Yue Wei Han
CHM | Chairman | 56 | 19-10-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 56 | 16-05-31 |
Ke Jian Zhang
BRD | Director/Board Member | 68 | 16-06-19 |
Kin Fun Kwok
BRD | Director/Board Member | 75 | 16-06-19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.92% | 4 M€ | -27.92% | ||
| 0.52% | 2 M€ | -20.87% | - | |
| 0.12% | 4 M€ | -11.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 4.79 | +2.13% | 9 671 566 |
| 24-04-18 | 4.69 | -1.47% | 8,822,548 |
| 24-04-17 | 4.76 | +2.37% | 7,428,000 |
| 24-04-16 | 4.65 | -1.06% | 8,403,015 |
| 24-04-15 | 4.7 | -0.63% | 11,967,100 |
Delayed Quote Hong Kong S.E., April 19, 2024 at 04:08 am EDT
More quotes
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
4.79
HKD
Average target price
7.406
HKD
Spread / Average Target
+54.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.63% | 3.76B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- 3320 Stock
